<SEC-DOCUMENT>0000950170-23-040017.txt : 20230808
<SEC-HEADER>0000950170-23-040017.hdr.sgml : 20230808
<ACCEPTANCE-DATETIME>20230808181302
ACCESSION NUMBER:		0000950170-23-040017
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230808
DATE AS OF CHANGE:		20230808

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		231152831

	BUSINESS ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bain Capital Life Sciences Fund, L.P.
		CENTRAL INDEX KEY:			0001687968
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-516-2000

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001687968</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001029142</issuerCik>
<issuerName>Dynavax Technologies Corporation</issuerName>
<secFileNumber>001-34207</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">2100 Powell Street</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 720</street2>
<city xmlns="http://www.sec.gov/edgar/common">Emeryville			</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">94608</zipCode>
</issuerAddress>
<issuerContactPhone>510-848-5100</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>BAIN CAPITAL LIFE SCIENCES FUND, LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Affiliate</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Goldman Sachs &amp; Co. LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 West Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10282</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>1360717</noOfUnitsSold>
<aggregateMarketValue>20070575</aggregateMarketValue>
<noOfUnitsOutstanding>128797357</noOfUnitsOutstanding>
<approxSaleDate>08/08/2023</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>08/12/2019</acquiredDate>
<natureOfAcquisitionTransaction>Purchase of Common Stock in an underwritten public offering</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Underwriter</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>6826266</amountOfSecuritiesAcquired>
<paymentDate>08/12/2019</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>05/27/2020</acquiredDate>
<natureOfAcquisitionTransaction>Purchase of Common Stock in an underwritten public offering</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Underwriter</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>907145</amountOfSecuritiesAcquired>
<paymentDate>05/27/2020</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Bain Capital Life Sciences Fund, L.P.</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 Clarendon Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02116</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>05/18/2023</saleDate>
<amountOfSecuritiesSold>907145</amountOfSecuritiesSold>
<grossProceeds>9570380</grossProceeds>
</securitiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>BCIP Life Sciences Associates, LP</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 Clarendon Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02116</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>05/18/2023</saleDate>
<amountOfSecuritiesSold>92855</amountOfSecuritiesSold>
<grossProceeds>979620</grossProceeds>
</securitiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Bain Capital Life Sciences Fund, L.P.</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 Clarendon Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02116</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>06/14/2023</saleDate>
<amountOfSecuritiesSold>453572</amountOfSecuritiesSold>
<grossProceeds>5751293</grossProceeds>
</securitiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>BCIP Life Sciences Associates, LP</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 Clarendon Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02116</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>06/14/2023</saleDate>
<amountOfSecuritiesSold>46428</amountOfSecuritiesSold>
<grossProceeds>588707</grossProceeds>
</securitiesSoldInPast3Months>
<noticeSignature>
<noticeDate>08/08/2023</noticeDate>
<signature>/s/ Andrew Hack, as Partner of Bain Capital Life Sciences Investors, LLC</signature>
</noticeSignature>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
